Daily BriefsEvent-Driven

Daily Brief Event-Driven: HDFC/​​​​HDFC Bank Mega Merger: Index Implications as We Near Completion and more

In today’s briefing:

  • HDFC/​​​​HDFC Bank Mega Merger: Index Implications as We Near Completion
  • Tokyo Gas (9531 JP) Mega Buyback Announced
  • HSI Market Consultation: Foreign Companies, Industry Groups, HK Companies
  • STAR50 Index Rebalance Preview: Changes Depend on Minimum Listing History
  • Blackmores (BKL AU) Signs SID with Kirin Holdings (2503 JP)
  • Activision Blizzard – An Unsightly Mess
  • SSE50 Index Rebalance Preview: Five Changes Coming Up in June
  • Codan (CDA AU): Balancing Defence And Accelerated Preparedness
  • Quiddity Leaderboard ES50 Sep 23: Vonovia Deletion Seems Likely; US$1.2bn Flow for Wolters Kluwer
  • EQT/Dechra Pharmaceuticals: Generous Possible Offer

HDFC/​​​​HDFC Bank Mega Merger: Index Implications as We Near Completion

By Brian Freitas

  • Foreign shareholding has dropped in HDFC Limited and increased in HDFC Bank – the net effect is an increase in foreign room to just north of 18%.
  • The merger is expected to complete in Q2/Q3 when there will be buying from MSCI trackers. There will be adhoc inclusions to the NIFTY, Nifty Next 50 and SENSEX indices.
  • HDFC Limited (HDFC IN) trades 1.39% below the merger ratio with HDFC Bank (HDFCB IN) and also at a lower price to book.

Tokyo Gas (9531 JP) Mega Buyback Announced

By Travis Lundy

  • Five days ago, Tokyo Gas (9531 JP) announced a revision to earnings for the year to 31 March 2023. Today they reported results, and announced March 2024 guidance.
  • The company also announced a buyback programme to spend up to ¥113 billion to repurchase up to 53mm shares (12.2% of TSO). ¥113 billion is a very specific number. 
  • With the price where it is, ¥113bn is “only” 9.6% of shares out but this is very interesting indeed.

HSI Market Consultation: Foreign Companies, Industry Groups, HK Companies

By Brian Freitas

  • Hang Seng Indexes has started a consultation on the eligibility of Foreign Companies in the Hang Seng Index, a review of the seven Industry Groups and number of HK constituents.
  • We agree that foreign companies should be added to the index, no change needed to the Industry Groups, and the cap on the number of HK constituents should be removed.
  • There are a few potential adds due to the removal of the cap on HK companies, while there are potential foreign company additions later this year or in 2024.

STAR50 Index Rebalance Preview: Changes Depend on Minimum Listing History

By Brian Freitas

  • The review period for the June rebalance ends 28 April. We expect the changes to be announced 26 May with the implementation taking place after the close on 9 June.
  • Using a 12-month minimum listing history results in no index changes. Using a 6-month minimum listing history results in two changes – we think this is what will be used.
  • The potential adds have outperformed the potential deletes but both sets of stocks have underperformed the SSE STAR50 (STAR50 INDEX) and the CSI Smallcap 500 Index – Shanghai (SH000905 INDEX)

Blackmores (BKL AU) Signs SID with Kirin Holdings (2503 JP)

By Brian Freitas

  • Blackmores Ltd (BKL AU) has signed a Scheme Implementation Deed with Kirin Holdings (2503 JP) for the acquisition of 100% of Blackmores by way of a scheme of arrangement.
  • The A$95/share offer is a 23.7% premium to the last close and is at least a 20% premium to most other VWAPs.
  • Blackmores Ltd (BKL AU) intends to pay a fully-franked special dividend of A$3.34/share. This will enable eligible shareholders to benefit from franking credits of A$1.43/share.

Activision Blizzard – An Unsightly Mess

By Mio Kato

  • Last night the CMA chose to block the merger between Microsoft and Activision Blizzard in the UK on the grounds that it would harm competition in cloud gaming. 
  • The merits of that position are highly debatable in our view but that does not mean that the decision is bad for consumers. 
  • It also does not mean that the decision is bad for Microsoft in our view.

SSE50 Index Rebalance Preview: Five Changes Coming Up in June

By Brian Freitas

  • With 2 trading days left in the review period, we see 7 potential adds/5 potential deletes in June. However, there can be a maximum of 5 changes at a rebalance.
  • We estimate one-way turnover of 5.58% at the June rebalance leading to a one-way trade of CNY 4.22bn. Index arb balances could increase the impact on the stocks.
  • The potential adds have outperformed the potential deletes over the last couple of months and have underperformed over the last week.

Codan (CDA AU): Balancing Defence And Accelerated Preparedness

By David Blennerhassett

  • The highly-anticipated Defence Strategic Review, released on the 24 April, clarifies the five key missions for the Australian Defence Force: maritime, land, air, space, and cyber.
  • One takeaway recommended Defence balance the need for local content against its timely acquisition, suggesting increased off-the-shelf acquisitions. This may favour overseas contractors in place of the domestic industry.
  • Codan (CDA AU), whose metal detectors and communications technology are used by the military, is one SME whose procurement speed may be scrutinised. 

Quiddity Leaderboard ES50 Sep 23: Vonovia Deletion Seems Likely; US$1.2bn Flow for Wolters Kluwer

By Janaghan Jeyakumar, CFA

  • The EURO STX 50 Index is one of the most highly-tracked indices in mainland Europe and the annual index review takes place in September.
  • Historically, these Rebalance events have had significant volume and ADV impact and they generally involve large cap names. 
  • In this insight, we take a look the names leading the race to become ADDs/DELs for the upcoming index review in September 2023.

EQT/Dechra Pharmaceuticals: Generous Possible Offer

By Jesus Rodriguez Aguilar

  • Dechra is in discussions with EQT and ADIA about a 4,070 cash possible offer (46.6% premium, 22.6x EV/NTM Fwd EBITDA and 32x Fwd P/E). PUSU deadline is 11 May. 
  • With the deal multiple at a slight premium (on both EV/Fwd EBITDA and Fwd P/E) over Zoetis, the market leader in animal health, the offer appears to be reasonably priced.
  • My base case fair value estimate is 3,568p/share (DCF-based), 12.3% below the offer price. My TP is thus 4,070p. Gross spread is 9.1%, therefore I feel the risk/reward is balanced.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars